BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9234594)

  • 1. Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients.
    Di Mario A; Sica S; Salutari P; Ortu La Barbera E; Marra R; Leone G
    Haematologica; 1997; 82(3):362-3. PubMed ID: 9234594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis.
    Olalla I; Ortín M; Hermida G; Cortés MA; Richard C; Iriondo A; Mozota ML; Zubizarreta A
    Bone Marrow Transplant; 1996 Dec; 18(6):1183-4. PubMed ID: 8971393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole resistance of Candida krusei.
    Manso E; Montillo M; Discepoli G; Leoni P
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions.
    Illerhaus G; Wirth K; Dwenger A; Waller CF; Garbe A; Brass V; Lang H; Lange W
    Ann Hematol; 2002 May; 81(5):273-81. PubMed ID: 12029537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
    Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
    Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
    Grigull L; Schrauder A; Schmitt-Thomssen A; Sykora K; Welte K
    Infection; 2002 Oct; 30(5):267-71. PubMed ID: 12382084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
    Catalano L; Fontana R; Scarpato N; Picardi M; Rocco S; Rotoli B
    Haematologica; 1997; 82(1):71-2. PubMed ID: 9107088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and controversies in the management of hematogenous candidiasis.
    Uzun O; Anaissie EJ
    Clin Infect Dis; 1996 May; 22 Suppl 2():S95-101. PubMed ID: 8722835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S11-4. PubMed ID: 15250015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 20. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.